Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
232.23
Oct 30 • 3:59 PM ET Dollar change-4.75 Percentage change(-2.00%)
Aftermarket Close
233.00
Aftermarket • 7:47 PM ET Dollar change+0.77 Percentage change(0.33%)
Index
S&P 500
Market Cap
163.38B
Enterprise Value
185.49B
Income
4.33B
Sales
25.61B
Book/sh
76.23
Cash/sh
8.08
Employees
60000
IPO
Dec 10, 1969
P/E
38.03
Forward P/E
24.94
PEG
2.63
P/S
6.38
P/B
3.05
P/C
28.75
P/FCF
28.53
EV/EBITDA
23.21
EV/Sales
7.24
Quick Ratio
1.29
Current Ratio
1.63
Debt/Eq
0.52
LT Debt/Eq
0.45
Option/Short
Yes / Yes
EPS (ttm)
6.11
EPS next Y
9.31
EPS next Q
2.48
EPS this Y
10.09%
EPS next Y
8.44%
EPS next 5Y
9.48%
EPS past 3/5Y
-19.39% 0.65%
Sales past 3/5Y
-2.67% 1.97%
EPS Y/Y TTM
25.53%
Sales Y/Y TTM
5.52%
EPS Q/Q
37.34%
Sales Q/Q
8.28%
Insider Own
8.98%
Insider Trans
-0.15%
Inst Own
84.00%
Inst Trans
-1.05%
ROA
4.95%
ROE
8.19%
ROIC
5.55%
Gross Margin
58.85%
Oper. Margin
20.94%
Profit Margin
16.91%
SMA20
2.46%
SMA50
6.11%
SMA200
15.47%
Trades
Shs Outstand
703.40M
Shs Float
640.36M
52W High
242.80 -4.35%
52W Low
160.93 44.30%
Volatility
2.54% 3.00%
ATR (14)
6.64
RSI (14)
58.12
Beta
0.78
Rel Volume
0.93
Avg Volume
4.04M
Volume
3,755,006
Perf Week
0.75%
Perf Month
9.67%
Perf Quarter
17.58%
Perf Half Y
32.59%
Perf YTD
1.45%
Perf Year
7.99%
Perf 3Y
25.46%
Perf 5Y
-15.97%
Perf 10Y
235.07%
Prev Close
236.98
Price
232.23
Change %
-2.00%
Consensus
Buy
Avg. Price Target
$259.95
Implied Upside
+11.9%
Analysts17incl. previous ratings
Rating Distribution12 Buy · 5 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Sep 09, 2026Resumed
UBS logoUUBS
Buy$250+7.7%
Jun 11, 2026Initiated
PPiper Sandler
Neutral$200-13.9%
Jun 03, 2026Initiated
DDZ Bank
Buy$210-9.6%
Jun 02, 2026Resumed
WWolfe Research
Peer Perform
May 26, 2026Resumed
C logoCCitigroup
Buy$230-1.0%
May 15, 2026Resumed
RY logoRRBC Capital Mkts
Outperform$200-13.9%
Dec 09, 2025Initiated
GS logoGGoldman
Buy$265+14.1%
Dec 02, 2025Initiated
MS logoMMorgan Stanley
Overweight$270+16.3%
Oct 08, 2025Downgrade
RRothschild & Co Redburn
Buy → Neutral$220-5.3%
Jul 11, 2025Upgrade
BNS logoBScotiabank
Sector Perform → Sector Outperform$275+18.4%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bouda ChristopherVP, Chief Accounting OfficerOct 28 '26Option Exercise70.747,598537,48313,452Oct 29 05:00 PM
Bouda ChristopherVP, Chief Accounting OfficerOct 28 '26Sale234.567,5981,782,1579,107Oct 29 05:00 PM
McGrew MatthewExecutive Vice PresidentOct 28 '26Option Exercise76.4715,6031,193,16128,277Oct 29 05:00 PM
McGrew MatthewExecutive Vice PresidentOct 28 '26Sale235.7429,7547,014,24412,674Oct 29 05:00 PM
McGrew MatthewOfficerOct 28 '26Proposed Sale235.7429,7547,014,244Oct 28 12:27 PM
Blair RainerPresident & CEOAug 21 '26Sale218.6358,25512,736,0950Aug 24 05:00 PM
Rainer M. BlairOfficerAug 21 '26Proposed Sale218.8558,25512,749,107Aug 21 04:46 PM
FILLER LINDADirectorJul 15 '26Option Exercise71.883,298237,06028,010Jul 16 05:00 PM
Zerhouni Elias A.DirectorJul 15 '26Option Exercise71.883,298237,06046,484Jul 16 05:00 PM
SCHWIETERS JOHN TFormer DirectorJul 14 '26Proposed Sale199.593,298658,254Jul 14 11:15 AM
SPOON ALAN GDirectorMay 01 '26Option Exercise71.883,298237,060125,452May 04 05:00 PM
SPOON ALAN GDirectorMay 01 '26Sale174.671,358237,207124,094May 04 05:00 PM
SPOON ALAN GDirectorMay 01 '26Proposed Sale174.671,358237,207May 01 03:05 PM
Milosevich Gregory MExecutive Vice PresidentFeb 19 '26Option Exercise58.591,32077,3396,419Feb 20 05:00 PM
Milosevich Gregory MExecutive Vice PresidentFeb 19 '26Sale208.011,320274,5755,099Feb 20 05:00 PM
Milosevich Gregory MOfficerFeb 19 '26Proposed Sale208.011,320274,575Feb 19 01:07 PM
RALES MITCHELL PChairman of Exec. CommitteeNov 25 '25Sale230.3840,6259,359,067850,000Nov 26 04:30 PM
The Mitchell P. Rales Family TSee RemarksNov 25 '25Proposed Sale226.9840,6259,221,063Nov 25 05:23 PM
Glenstone FoundationSee RemarksNov 25 '25Proposed Sale226.98146,95733,356,300Nov 25 05:22 PM
List TeriDirectorNov 18 '25Option Exercise71.883,298237,06024,060Nov 19 05:00 PM
List TeriDirectorNov 18 '25Sale226.503,298746,99720,762Nov 19 05:00 PM
List TeriDirectorNov 18 '25Proposed Sale226.503,298746,997Nov 18 03:32 PM
McGrew MatthewEVP & Chief Financial OfficerNov 11 '25Option Exercise62.8516,1721,016,41036,234Nov 13 05:00 PM
McGrew MatthewEVP & Chief Financial OfficerNov 11 '25Sale214.6216,1723,470,83120,062Nov 13 05:00 PM
Ellis Brian WSenior Vice President - GCNov 12 '25Option Exercise58.5921,7761,275,85629,220Nov 13 05:00 PM
Ellis Brian WSenior Vice President - GCNov 12 '25Sale219.2321,7764,773,86314,553Nov 13 05:00 PM
RALES MITCHELL PChairman of Exec. CommitteeNov 12 '25Sale218.69437,00095,566,167553,228Nov 13 04:30 PM
Couchara GeorgeannSVP, Human ResourcesNov 10 '25Option Exercise88.244,176368,4907,799Nov 12 05:00 PM
Couchara GeorgeannSVP, Human ResourcesNov 10 '25Sale210.425,1741,088,7042,625Nov 12 05:00 PM
Mitchell P. RalesDir; Chmn. of Exec. Comm.Nov 12 '25Proposed Sale209.94437,00091,743,780Nov 12 04:30 PM
Ellis Brian WOfficerNov 12 '25Proposed Sale219.2321,7764,773,864Nov 12 02:35 PM
McGrew MatthewOfficerNov 11 '25Proposed Sale214.6216,1723,470,831Nov 12 08:56 AM
Couchara GeorgeannOfficerNov 10 '25Proposed Sale210.425,1741,088,704Nov 10 02:46 PM
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment includes bioprocessing, discovery, and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.
Co-Founder & ChairmanMr. Steven M. Rales
PresidentMs. Julie Sawyer Montgomery
Co-Founder & DirectorMr. Mitchell P. Rales
Senior VP & Chief Science OfficerDr. Jose-Carlos Gutierrez-Ramos Ph.D.
Executive Vice PresidentMr. Matthew R. McGrew